glp 1 glucagon Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Glucagon-like peptide-1 - Wikipedia

Combination pharmacotherapy with GLP-1RAs and other treatments (e.g., GIP agonists, SGLT2 inhibitors, or amylin analogs) is an exciting frontier for weight and metabolic benefit [79]

Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance

S., Amaro, A., et al

Over a longer 2-year trial, the rate of GI adverse events climbed to 82% on semaglutide (source)

Here are a few foundational strategies I often discuss with clients: Eat smaller meals more often instead of forcing large portions

For physicians practicing functional and anti-aging medicine, the critical metric is the improvement in underlying cardiovascular and metabolic markers